CD47 and lung carcinoma: These data indicate that the mechanism of anti-CD47 antibody to inhibit cancer cells or CSC growth is unlikely to be that these antibodies induce apoptosis of lung cancer cells or CSCs that are then secondarily phagocytosed or directly inhibit proliferation of lung cancer cells.